Publication:
Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors

dc.contributor.authorLeechaisit R.
dc.contributor.authorPingaew R.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:02:35Z
dc.date.available2021-04-05T03:02:35Z
dc.date.issued2019
dc.date.issuedBE2562
dc.description.abstractA library of bis-sulfonamides (9–26) were synthesized and tested for their aromatase inhibitory activities. Interestingly, all bis-sulfonamide derivatives inhibited the aromatase with IC50 range of 0.05–11.6 μM except for compound 23. The analogs 15 and 16 bearing hydrophobic chloro and bromo groups exhibited the potent aromatase inhibitory activity in sub-micromolar IC50 values (i.e., 50 and 60 nM, respectively) with high safety index. Molecular docking revealed that the chloro and bromo benzenesulfonamides (15 and 16) may play role in the hydrophobic interaction with Leu477 of the aromatase to mimic steroidal backbone of the natural substrate, androstenedione. QSAR study also revealed that the most potent activity of compounds was governed by van der Waals volume (GATS6v) and mass (Mor03m) descriptors. Finally, the two compounds (15 and 16) were highlighted as promising compounds to be further developed as novel aromatase inhibitors. © 2019 Elsevier Ltd
dc.format.mimetypeapplication/pdf
dc.identifier.citationBioorganic and Medicinal Chemistry. Vol 27, No.19 (2019)
dc.identifier.doi10.1016/j.bmc.2019.08.001
dc.identifier.issn9680896
dc.identifier.other2-s2.0-85070395327
dc.identifier.urihttps://hdl.handle.net/20.500.14740/5135
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherAndrostenedione
dc.subject.otherAromatase
dc.subject.otherBenzenesulfonamide derivative
dc.subject.otherDoxorubicin
dc.subject.otherLetrozole
dc.subject.otherN,n' (1,3 phenylene)bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' (1,3 phenylene)bis(4 methoxybenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(2 nitrobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(3 aminobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(3 nitrobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 acetylbenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 bromobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 chlorobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 fluorobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 methoxybenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 methylbenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 nitrobenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subject.otherN,n' [1,3 phenylenebis(methylene)]bis(naphthalene 2 sulfonamide)
dc.subject.otherN,n' [1,4 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subject.otherN,n' [1,4 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subject.otherSulfonamide
dc.subject.otherUnclassified drug
dc.subject.otherAromatase
dc.subject.otherAromatase inhibitor
dc.subject.otherProtein binding
dc.subject.otherSulfonamide
dc.subject.otherArticle
dc.subject.otherBreast cancer
dc.subject.otherControlled study
dc.subject.otherDrug cytotoxicity
dc.subject.otherDrug potency
dc.subject.otherDrug safety
dc.subject.otherDrug structure
dc.subject.otherDrug synthesis
dc.subject.otherEnzyme inhibition
dc.subject.otherHydrophobicity
dc.subject.otherIC50
dc.subject.otherMolecular docking
dc.subject.otherMRC-5 cell line
dc.subject.otherQuantitative structure activity relation
dc.subject.otherStructure activity relation
dc.subject.otherT-47D cell line
dc.subject.otherBinding site
dc.subject.otherChemical structure
dc.subject.otherChemistry
dc.subject.otherHuman
dc.subject.otherMetabolism
dc.subject.otherMolecular library
dc.subject.otherPharmacology
dc.subject.otherSynthesis
dc.subject.otherTumor cell line
dc.subject.otherAromatase
dc.subject.otherAromatase Inhibitors
dc.subject.otherBinding Sites
dc.subject.otherCell Line, Tumor
dc.subject.otherHumans
dc.subject.otherMolecular Docking Simulation
dc.subject.otherMolecular Structure
dc.subject.otherProtein Binding
dc.subject.otherQuantitative Structure-Activity Relationship
dc.subject.otherSmall Molecule Libraries
dc.subject.otherSulfonamides
dc.titleSynthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070395327&doi=10.1016%2fj.bmc.2019.08.001&partnerID=40&md5=6bf733408e7c36b895365a553545d17e

Files